Showing results (21-30 of 235) with videos related to
Sort By:
Pageof 24
Biochimica Et Biophysica Acta|December 12, 1997
The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapyA Strasser, D C Huang, D L VauxThe EMBO Journal|January 16, 1999
Inhibition of apoptosis and clonogenic survival of cells expressing crmA variants: optimal caspase substrates are not necessarily optimal inhibitorsP G Ekert, J Silke, D L VauxCell|May 6, 1994
Expression of the integrin alpha 4 beta 1 on melanoma cells can inhibit the invasive stage of metastasis formationF Qian, D L Vaux, I L WeissmanThe EMBO Journal|October 1, 1996
CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune diseaseK G Smith, A Strasser, D L VauxMicroscopy Research and Technique|June 15, 1996
Activation of physiological cell death mechanisms by a necrosis-causing agentD L Vaux, D Whitney, I L WeissmanNature|September 29, 1988
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cellsD L Vaux, S Cory, J M AdamsInternational Immunology|July 1, 1992
Bcl-2 prevents death of factor-deprived cells but fails to prevent apoptosis in targets of cell mediated killingD L Vaux, H L Aguila, I L WeissmanGenome Biology|August 23, 2001
Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPsA M Verhagen, E J Coulson, D L VauxProceedings of the National Academy of Sciences of the United States of America|December 1, 1981
Antibody production by single, hapten-specific B lymphocytes: an antigen-driven cloning system free of filler or accessory cellsD L Vaux, B L Pike, G J NossalPageof 24